Faes Farma
€4.55Change from previous close: 0.00%
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €1.42B
- Enterprise value
- €1.73B
- P/E (trailing 12 months)
- 16.9
- Forward P/E
- 12.9
- PEG
- 0.91
- Price/book
- 1.83
- Price/sales
- 1.99
- EV/EBITDA
- 13.8
- EV/revenue
- 2.43
Profitability and growth
- Gross margin
- 65.2%
- Operating margin
- 17.0%
- Net margin
- 11.8%
- ROE
- 11.2%
- ROA
- 5.0%
- Revenue growth (year over year)
- 24.0%
- Earnings growth (year over year)
- 8.9%
Financial health
- Total cash
- €136.78M
- Total debt
- €449.29M
- Debt/equity
- 0.58
- Current ratio
- 2.63
- Quick ratio
- 1.66
Dividends
- Annual dividend per share
- €0.13
- Dividend yield
- 2.8%
- Payout ratio
- 47.8%
- Ex-dividend date
- July 2, 2026
Analysts and estimates
- Average price target
- €5.36
- Median price target
- €5.30
- High price target
- €6.00
- Low price target
- €4.82
- Analysts with a price target
- 4
- Forward EPS
- €0.35
- EPS estimate, current year
- €0.30
Shares and trading
- Beta
- 0.34
- Average volume
- 139.6K
- Shares outstanding
- 311.45M
- Float
- 217.25M
- Institutional ownership
- 15.8%
- Insider ownership
- 20.4%